lanadelumab
ItalyDrugs containing this active substance
-
TAKHZYRO is used to prevent angioedema attacks (HAE) in patients aged 2 years and older.
Form: solution for injection
Active substance Dosage lanadelumab - ATC: B06AC05
Manufacturer: TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH